These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8585764)

  • 1. Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogs.
    Azad RF; Brown-Driver V; Buckheit RW; Anderson KP
    Antiviral Res; 1995 Oct; 28(2):101-11. PubMed ID: 8585764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region.
    Azad RF; Driver VB; Tanaka K; Crooke RM; Anderson KP
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1945-54. PubMed ID: 8239610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.
    Eriksson BF; Schinazi RF
    Antimicrob Agents Chemother; 1989 May; 33(5):663-9. PubMed ID: 2546487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts.
    Cinatl J; Kotchetkov R; Weimer E; Blaheta RA; Scholz M; Vogel JU; Gümbel HO; Doerr HW
    J Med Virol; 2000 Mar; 60(3):313-23. PubMed ID: 10630964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
    Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
    Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
    Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of human immunodeficiency virus isolates (including 3'-azido-3'-deoxythymidine-resistant isolates) by foscarnet in combination with 2',3'-dideoxyinosine or 2',3'-dideoxycytidine.
    Palmer S; Harmenberg J; Cox S
    Antimicrob Agents Chemother; 1996 May; 40(5):1285-8. PubMed ID: 8723486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA
    Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
    Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA.
    Anderson KP; Fox MC; Brown-Driver V; Martin MJ; Azad RF
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2004-11. PubMed ID: 8878571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
    Takahashi K
    Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisheteroarylpiperazine reverse transcriptase inhibitor in combination with 3'-azido-3'-deoxythymidine or 2',3'-dideoxycytidine synergistically inhibits human immunodeficiency virus type 1 replication in vitro.
    Chong KT; Pagano PJ; Hinshaw RR
    Antimicrob Agents Chemother; 1994 Feb; 38(2):288-93. PubMed ID: 7514857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring system.
    Lewis AF; Drach JC; Fennewald SM; Huffman JH; Ptak RG; Sommadossi JP; Revankar GR; Rando RF
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2889-95. PubMed ID: 7695278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Artemisinin Derivative Artemisone Is a Potent Inhibitor of Human Cytomegalovirus Replication.
    Oiknine-Djian E; Weisblum Y; Panet A; Wong HN; Haynes RK; Wolf DG
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum.
    Lee JB; Hayashi K; Hayashi T; Sankawa U; Maeda M
    Planta Med; 1999 Jun; 65(5):439-41. PubMed ID: 10418331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.
    Hoke GD; Draper K; Freier SM; Gonzalez C; Driver VB; Zounes MC; Ecker DJ
    Nucleic Acids Res; 1991 Oct; 19(20):5743-8. PubMed ID: 1658742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37.
    Pari GS; Field AK; Smith JA
    Antimicrob Agents Chemother; 1995 May; 39(5):1157-61. PubMed ID: 7625805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.
    Evers DL; Komazin G; Shin D; Hwang DD; Townsend LB; Drach JC
    Antiviral Res; 2002 Oct; 56(1):61-72. PubMed ID: 12323400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double resistance to ganciclovir and foscarnet of four human cytomegalovirus strains recovered from AIDS patients.
    Sarasini A; Baldanti F; Furione M; Percivalle E; Brerra R; Barbi M; Gerna G
    J Med Virol; 1995 Nov; 47(3):237-44. PubMed ID: 8551275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.